The DOI matches its Crossref record; 20 of the 20 references it cites were found in a registry or an index.
A Randomized Trial of Intravenous Alteplase before Endovascular Treatment for Stroke
Open accessAbstract
BACKGROUND: The value of administering intravenous alteplase before endovascular treatment (EVT) for acute ischemic stroke has not been studied extensively, particularly in non-Asian populations. METHODS: We performed an open-label, multicenter, randomized trial in Europe involving patients with stroke who presented directly to a hospital that was capable of providing EVT and who were eligible for intravenous alteplase and EVT. Patients were randomly assigned in a 1:1 ratio to receive EVT alone or intravenous alteplase followed by EVT (the standard of care). The primary end point was functional outcome on the modified Rankin scale (range, 0 [no disability] to 6 [death]) at 90 days. We assessed the superiority of EVT alone over alteplase plus EVT, as well as noninferiority by a margin of 0.8 for the lower boundary of the 95% confidence interval for the odds ratio of the two trial groups. Death from any cause and symptomatic intracerebral hemorrhage were the main safety end points. RESULTS: The analysis included 539 patients. The median score on the modified Rankin scale at 90 days was 3 (interquartile range, 2 to 5) with EVT alone and 2 (interquartile range, 2 to 5) with alteplase plus EVT. The adjusted common odds ratio was 0.84 (95% confidence interval [CI], 0.62 to 1.15; P = 0.28), which showed neither superiority nor noninferiority of EVT alone. Mortality was 20.5% with EVT alone and 15.8% with alteplase plus EVT (adjusted odds ratio, 1.39; 95% CI, 0.84 to 2.30). Symptomatic intracerebral hemorrhage occurred in 5.9% and 5.3% of the patients in the respective groups (adjusted odds ratio, 1.30; 95% CI, 0.60 to 2.81). CONCLUSIONS: In a randomized trial involving European patients, EVT alone was neither superior nor noninferior to intravenous alteplase followed by EVT with regard to disability outcome at 90 days after stroke. The incidence of symptomatic intracerebral hemorrhage was similar in the two groups. (Funded by the Collaboration for New Treatments of Acute Stroke consortium and others; MR CLEAN-NO IV ISRCTN number, ISRCTN80619088.).
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
EuroQol: a new facility for the measurement of health-related quality of life
(1990) · Health Policy · doi:10.1016/0168-8510(90)90421-9 · Cited by 15,736
Goyal, M., Menon, B. K., van Zwam, W. H., Dippel, D. W. J., Mitchell, P. J., Demchuk, A. M., Dávalos, A., Majoie, C. B. L. M., van der Lugt, A., de Miquel, M. A., et al. (2016) · The Lancet · doi:10.1016/s0140-6736(16)00163-x · Cited by 7,815
Self-citationPowers, W. J., Rabinstein, A. A., Ackerson, T., Adeoye, O. M., Bambakidis, N. C., Becker, K., Biller, J., Brown, M., Demaerschalk, B. M., Hoh, B., et al. (2019) · Stroke · doi:10.1161/str.0000000000000211 · Cited by 7,468
A Randomized Trial of Intraarterial Treatment for Acute Ischemic Stroke
Berkhemer, O. A., Fransen, P. S. S., Beumer, D., van den Berg, L. A., Lingsma, H. F., Yoo, A. J., Schonewille, W. J., Vos, J. A., Nederkoorn, P. J., Wermer, M. J. H., et al. (2015) · New England Journal of Medicine · doi:10.1056/nejmoa1411587 · Cited by 6,657
Self-citationRandomized Assessment of Rapid Endovascular Treatment of Ischemic Stroke
Goyal, M., Demchuk, A. M., Menon, B. K., Eesa, M., Rempel, J. L., Thornton, J., Roy, D., Jovin, T. G., Willinsky, R. A., Sapkota, B. L., et al. (2015) · New England Journal of Medicine · doi:10.1056/nejmoa1414905 · Cited by 6,083
von Kummer, R., Broderick, J. P., Campbell, B. C. V., Demchuk, A., Goyal, M., Hill, M. D., Treurniet, K. M., Majoie, C. B. L. M., Marquering, H. A., Mazya, M. V., et al. (2015) · Stroke · doi:10.1161/strokeaha.115.010049 · Cited by 1,409
Self-citationWilson, J. T. L., Hareendran, A., Grant, M., Baird, T., Schulz, U. G. R., Muir, K. W., & Bone, I. (2002) · Stroke · doi:10.1161/01.str.0000027437.22450.bd · Cited by 855
Endovascular Thrombectomy with or without Intravenous Alteplase in Acute Stroke
Yang, P., Zhang, Y., Zhang, L., Zhang, Y., Treurniet, K. M., Chen, W., Peng, Y., Han, H., Wang, J., Wang, S., et al. (2020) · New England Journal of Medicine · doi:10.1056/nejmoa2001123 · Cited by 829
Self-citationInterobserver agreement for the assessment of handicap in stroke patients.
Bamford, J. M., Sandercock, P. A., Warlow, C. P., & Slattery, J. (1989) · Stroke · doi:10.1161/01.str.20.6.828 · Cited by 693
Suzuki, K., Matsumaru, Y., Takeuchi, M., Morimoto, M., Kanazawa, R., Takayama, Y., Kamiya, Y., Shigeta, K., Okubo, S., Hayakawa, M., et al. (2021) · JAMA · doi:10.1001/jama.2020.23522 · Cited by 545
Cited by
Fischer, U., Kaesmacher, J., Strbian, D., Eker, O., Cognard, C., Plattner, P. S., Bütikofer, L., Mordasini, P., Deppeler, S., Pereira, V. M., et al. (2022) · The Lancet · doi:10.1016/s0140-6736(22)00537-2 · Cited by 291
Self-citationMitchell, P. J., Yan, B., Churilov, L., Dowling, R. J., Bush, S. J., Bivard, A., Huo, X. C., Wang, G., Zhang, S. Y., Ton, M. D., et al. (2022) · The Lancet · doi:10.1016/s0140-6736(22)00564-5 · Cited by 229
Metadata
- Authors
- LeCouffe, N. E., Kappelhof, M., Treurniet, K. M., Rinkel, L. A., Bruggeman, A. E., Berkhemer, O. A., Wolff, L., van Voorst, H., Tolhuisen, M. L., Dippel, D. W. J., van der Lugt, A., van Es, A. C. G. M., Boiten, J., Lycklama à Nijeholt, G. J., Keizer, K., Gons, R. A. R., Yo, L. S. F., van Oostenbrugge, R. J., van Zwam, W. H., Roozenbeek, B., van der Worp, H. B., Lo, R. T. H., van den Wijngaard, I. R., de Ridder, I. R., Costalat, V., Arquizan, C., Lemmens, R., Demeestere, J., Hofmeijer, J., Martens, J. M., Schonewille, W. J., Vos, J.-A., Uyttenboogaart, M., Bokkers, R. P. H., van Tuijl, J. H., Kortman, H., Schreuder, F. H. B. M., Boogaarts, H. D., de Laat, K. F., van Dijk, L. C., den Hertog, H. M., van Hasselt, B. A. A. M., Brouwers, P. J. A. M., Bulut, T., Remmers, M. J. M., van Norden, A., Imani, F., Rozeman, A. D., Elgersma, O. E. H., Desfontaines, P., Brisbois, D., Samson, Y., Clarençon, F., Krietemeijer, G. M., Postma, A. A., van Doormaal, P.-J., van den Berg, R., van der Hoorn, A., Beenen, L. F. M., Nieboer, D., Lingsma, H. F., Emmer, B. J., Coutinho, J. M., Majoie, C. B. L. M., & Roos, Y. B. W. E. M.
- Venue
- New England Journal of Medicine
- Publisher
- Massachusetts Medical Society
- Published
- 2021-11-11
- Volume
- 385
- Issue
- 20
- Pages
- 1833-1844
- ISSN
- 0028-4793 (ISSN-L)
- 1533-4406
- OpenAlex
- W3211535388
- Cited by
- 408
- References
- 20
- FWCI
- 46.11
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: A Randomized Trial of Intravenous Alteplase before Endovascular Treatment for Stroke. https://app.cochat.ai/papers/10.1056/nejmoa2107727
- The paper
- LeCouffe, N. E., Kappelhof, M., Treurniet, K. M., Rinkel, L. A., Bruggeman, A. E., Berkhemer, O. A., Wolff, L., van Voorst, H., Tolhuisen, M. L., Dippel, D. W. J., van der Lugt, A., van Es, A. C. G. M., Boiten, J., Lycklama à Nijeholt, G. J., Keizer, K., Gons, R. A. R., Yo, L. S. F., van Oostenbrugge, R. J., van Zwam, W. H., . . . Roos, Y. B. W. E. M. (2021). A Randomized Trial of Intravenous Alteplase before Endovascular Treatment for Stroke. New England Journal of Medicine. https://doi.org/10.1056/nejmoa2107727
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.